Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Leukemia

Free Subscription Articles published in Acta Haematol Retrieve available abstracts of 91 articles: HTML format

Single Articles

April 2024
1. NASNAS PE, Jabbour EJ, Sasaki K, Issa GC, et al
   Failure of treatment-free remission after a prolonged deep molecular response in patients with chronic myeloid leukemia.
   Acta Haematol. 2024 Apr 4. doi: 10.1159/000538651.
   PubMed     Abstract available
   
   
   March 2024
2. PAN L, Zheng Y, Zheng H
   Long Non-coding RNA RP11-252C15.1 is a Potential Biomarker of Prognosis and Hallmark for Leukemogenesis in Children with B-cell Precursor Acute Lymphoblastic Leukemia.
   Acta Haematol. 2024 Mar 25. doi: 10.1159/000535461.
   PubMed     Abstract available
   
   
   
3. BENJAMINI O, Tadmor T, Avigdor A, Gershon R, et al
   Efficacy of preexposure prophylaxis with monoclonal-antibody tixagevimab-cilgavimab against emerging SARS-CoV-2 resistant variants in patients with chronic lymphocytic leukemia.
   Acta Haematol. 2024 Mar 12. doi: 10.1159/000537690.
   PubMed     Abstract available
   
   
   
4. SHAPIRA S, Hirschberger N, Ofran Y, Mizrahi B, et al
   The effect of mind-body intervention on lymphocyte doubling time and treatment free survival in treatment-naive chronic lymphocytic leukemia patients.
   Acta Haematol. 2024 Mar 8. doi: 10.1159/000538055.
   PubMed     Abstract available
   
   
   
5. MORIGUCHI M, Ido K, Okamura H, Nakamae M, et al
   Impacts of Posttransplant Cyclophosphamide Dose on Graft-versus-leukemia Effects via HLA-B Leader in HLA-haploidentical Peripheral Blood Stem Cell Transplantation.
   Acta Haematol. 2024 Mar 1. doi: 10.1159/000538078.
   PubMed     Abstract available
   
   
   February 2024
6. PARIGGER T, Drothler S, Scherhaufl C, Gassner FJ, et al
   Oncogenic MTOR signaling axis compensates BTK inhibition in a Chronic Lymphocytic Leukemia patient with Richter Transformation: A Case Report and Review of the Literature.
   Acta Haematol. 2024 Feb 24. doi: 10.1159/000537791.
   PubMed     Abstract available
   
   
   
7. LACHAINE J, Beauchemin C, Dodat F, Au Y, et al
   Evaluating the economic burden of acute myeloid leukemia in Canada.
   Acta Haematol. 2024 Feb 21. doi: 10.1159/000537725.
   PubMed     Abstract available
   
   
   
8. ZHANG Q, Dong Y, Zhai Z, Tao L, et al
   Lenalidomide treatment of isolated central nervous system relapse in acute lymphoblastic leukemia after HSCT and CAR-T cell therapy.
   Acta Haematol. 2024 Feb 15. doi: 10.1159/000537719.
   PubMed     Abstract available
   
   
   
9. ZHONG T, Xu D, Li W
   Prevalence, risk factors, and prognostic value of anxiety and depression in acute myeloid leukemia.
   Acta Haematol. 2024 Feb 11. doi: 10.1159/000536457.
   PubMed     Abstract available
   
   
   January 2024
10. HU GH, Zhang XH, Liu KY, Xu LP, et al
    Outcome and prognostic factors of haploidentical allogeneic hematopoietic stem cell transplantation in pediatric relapsed or refractory ETV6/RUNX1-positive acute lymphoblastic leukemia.
    Acta Haematol. 2024 Jan 20. doi: 10.1159/000536396.
    PubMed     Abstract available
    
    
    
11. WACHTER F, Pikman Y
    Pathophysiology of Acute Myeloid Leukemia (AML).
    Acta Haematol. 2024 Jan 16. doi: 10.1159/000536152.
    PubMed     Abstract available
    
    
    
12. TROUSSARD X
    Unusual clinical presentations of hairy cell leukemia.
    Acta Haematol. 2024 Jan 4. doi: 10.1159/000536043.
    PubMed    
    
    
    
13. AL-SAWAF O
    Importance of Minimal Residual Disease in the Era of Targeted Therapies in Chronic Lymphocytic Leukemia.
    Acta Haematol. 2024;147:22-32.
    PubMed     Abstract available
    
    
    
14. TADMOR T, Burger J
    Chronic Lymphocytic Leukemia: Novel Perspectives - How to Teach an Old Dog New Tricks.
    Acta Haematol. 2024;147:5-7.
    PubMed    
    
    
    
15. KANG S, Ahn IE
    Prognostic Markers in the Era of Targeted Therapies.
    Acta Haematol. 2024;147:33-46.
    PubMed     Abstract available
    
    
    
16. GARGIULO E, Teglgaard RS, Faitova T, Niemann CU, et al
    Immune Dysfunction and Infection - Interaction between CLL and Treatment: A Reflection on Current Treatment Paradigms and Unmet Needs.
    Acta Haematol. 2024;147:84-98.
    PubMed     Abstract available
    
    
    
17. CARLSON KS, Cunningham A, Stahl M, Winer E, et al
    Diagnostic Precision or Pitfalls: How to Apply the New Acute Myeloid Leukemia Classification Systems?
    Acta Haematol. 2024;147:122-132.
    PubMed     Abstract available
    
    
    
18. JIMENEZ-CHILLON C, Dillon R, Russell N
    Optimal Post-Remission Consolidation Therapy in Patients with AML.
    Acta Haematol. 2024;147:147-158.
    PubMed     Abstract available
    
    
    
19. BUCHRITS S, Wolach O
    Non-Immunotherapy Approaches for Relapsed or Refractory AML: An Update for 2024.
    Acta Haematol. 2024;147:159-174.
    PubMed     Abstract available
    
    
    December 2023
20. DIGENNARO J, Sallman DA
    TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Current Guidelines, Therapies and Future Considerations.
    Acta Haematol. 2023 Dec 5. doi: 10.1159/000535628.
    PubMed     Abstract available
    
    
    November 2023
21. WOODS JD, Klepin HD
    Geriatric assessment in Acute Myeloid Leukemia (AML).
    Acta Haematol. 2023 Nov 30. doi: 10.1159/000535500.
    PubMed     Abstract available
    
    
    
22. SHIMONY S, Stone RM
    Untangling Complexities of Acute Myeloid Leukemia Review Series.
    Acta Haematol. 2023 Nov 30. doi: 10.1159/000535574.
    PubMed    
    
    
    
23. BLACKMON AL, Hourigan CS
    Test then erase? Current status and future opportunities for Measurable Residual Disease testing in Acute Myeloid Leukemia.
    Acta Haematol. 2023 Nov 30. doi: 10.1159/000535463.
    PubMed     Abstract available
    
    
    
24. HOFFMAN T, Atamna A, Litchevsky V, Amitai I, et al
    Fluoroquinolone Prophylaxis During Conventional Chemotherapy or Hematopoietic Stem Cell Transplantation for Acute Leukemia - Pros and Cons.
    Acta Haematol. 2023 Nov 21. doi: 10.1159/000535119.
    PubMed     Abstract available
    
    
    
25. COWEN EA, Barrios DM, Pulitzer MP, Moy AP, et al
    Acute febrile neutrophilic dermatosis (Sweet syndrome) in acute myeloid leukemia patients: a 28-year institutional experience.
    Acta Haematol. 2023 Nov 21. doi: 10.1159/000535399.
    PubMed     Abstract available
    
    
    
26. RIOS-OLAIS FA, Gil-Lopez F, Mora-Canas A, Demichelis-Gomez R, et al
    Tumor lysis syndrome is associated with worse outcomes in adult patients with acute lymphoblastic leukemia.
    Acta Haematol. 2023 Nov 14. doi: 10.1159/000534453.
    PubMed     Abstract available
    
    
    
27. ITO K, Harada K, Uchino Y, Hirano K, et al
    A Rare Clinical Case of Secondary Central Nervous System Involvement without Transformation in Hairy Cell Leukemia: Case Report and Literature Review.
    Acta Haematol. 2023 Nov 10. doi: 10.1159/000535066.
    PubMed     Abstract available
    
    
    
28. ZHAO MN, Su L, Song F, Wei ZF, et al
    Shikonin exerts an anti-leukemia effect against FLT3-ITD mutated acute myeloid leukemia cells via targeting FLT3 tyrosine kinase and its downstream pathways.
    Acta Haematol. 2023 Nov 3. doi: 10.1159/000534101.
    PubMed     Abstract available
    
    
    October 2023
29. ARGUELLO-TOMAS M, Albiol N, Moreno C
    Frontline therapy in Chronic Lymphocytic Leukemia.
    Acta Haematol. 2023 Oct 27. doi: 10.1159/000534730.
    PubMed     Abstract available
    
    
    
30. SAUSSELE S, La Rosee P, Kiani A, Haverkamp W, et al
    Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia.
    Acta Haematol. 2023 Oct 17. doi: 10.1159/000533666.
    PubMed     Abstract available
    
    
    
31. MINCULESCU L, Reekie J, Petersen SL, Kornblit BT, et al
    Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation.
    Acta Haematol. 2023 Oct 12. doi: 10.1159/000534315.
    PubMed     Abstract available
    
    
    
32. HAREL R, Itchaki G
    COVID-19 in Patients with Chronic Lymphocytic Leukemia - What Have We Learned?
    Acta Haematol. 2023 Oct 11. doi: 10.1159/000534540.
    PubMed     Abstract available
    
    
    
33. KATZ OB, Yehudai-Ofir D, Zuckerman T
    Cellular therapy in chronic lymphocytic leukemia: have we advanced in the last decade?
    Acta Haematol. 2023 Oct 9. doi: 10.1159/000534341.
    PubMed     Abstract available
    
    
    
34. BELLO E, Liao H, Patel SA
    Clinico-Radio-Pathologic Correlation of Leukostasis in Acute Myeloid Leukemia with FLT3 Mutation.
    Acta Haematol. 2023 Oct 3. doi: 10.1159/000531832.
    PubMed     Abstract available
    
    
    September 2023
35. ALSHEMMARI SH, A Siddiqui M, Pandita R, Osman HY, et al
    Evidence-based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region.
    Acta Haematol. 2023 Sep 26. doi: 10.1159/000531675.
    PubMed     Abstract available
    
    
    
36. BAE S, Sa S, Park S, Cho BS, et al
    Limited efficacy of Venetoclax Combination Regimens in Acute Myeloid Leukemia with Extramedullary Relapse.
    Acta Haematol. 2023 Sep 26. doi: 10.1159/000534026.
    PubMed     Abstract available
    
    
    
37. SASTOW D, Van Hyfte G, Feld J, Kremyanskaya M, et al
    Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012-2022.
    Acta Haematol. 2023 Sep 26:1. doi: 10.1159/000533819.
    PubMed     Abstract available
    
    
    
38. KOEHRER S, Burger JA
    Chronic lymphocytic leukemia: disease biology.
    Acta Haematol. 2023 Sep 16. doi: 10.1159/000533610.
    PubMed     Abstract available
    
    
    
39. CHEN EC, Garcia JS
    Immunotherapy for acute myeloid leukemia: current trends, challenges, and strategies.
    Acta Haematol. 2023 Sep 6. doi: 10.1159/000533990.
    PubMed     Abstract available
    
    
    
40. LEVY YURKOVSKI I, Tadmor T
    Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents.
    Acta Haematol. 2023 Sep 4. doi: 10.1159/000533664.
    PubMed     Abstract available
    
    
    August 2023
41. SHI Y, Xu X, He Z, Tao H, et al
    AKAP12 and IGFBP4 are prognostic factors for chronic lymphocytic leukemia.
    Acta Haematol. 2023 Aug 21. doi: 10.1159/000530618.
    PubMed     Abstract available
    
    
    
42. EFSTATHOPOULOU M, Zoi K, Siakantaris MP, Koumbi D, et al
    A case report of Chronic myelogenous leukemia presenting as blastic crisis with a T-cell acute lymphoblastic leukemia phenotype: Awareness of a rare entity.
    Acta Haematol. 2023 Aug 9. doi: 10.1159/000529911.
    PubMed     Abstract available
    
    
    July 2023
43. CHOI J, Shukla M, Abdul-Hay M
    Acute Myeloid Leukemia Treatment in the Elderly: A Comprehensive Review of the Present and Future.
    Acta Haematol. 2023 Jul 17. doi: 10.1159/000531628.
    PubMed     Abstract available
    
    
    June 2023
44. TADMOR T, Melamed G, Alapi H, Gazit S, et al
    Pregnancy course of 10 women diagnosed with Chronic Lymphocytic Leukemia.
    Acta Haematol. 2023 Jun 5. doi: 10.1159/000531400.
    PubMed     Abstract available
    
    
    May 2023
45. MITTELMAN M, Platzbecker U, Grosicki S, Lawniczek T, et al
    Long-term Safety and Efficacy of Eltrombopag for Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia and Severe Thrombocytopenia: Results of the ASPIRE Extension Study.
    Acta Haematol. 2023 May 19. doi: 10.1159/000531146.
    PubMed     Abstract available
    
    
    
46. NISCOLA P, Mazzone C, Fratoni S, Ardu NR, et al
    Acute myeloid leukemia with NPM1 mutation and disseminated leukaemia cutis: achievement of molecular complete remission by venetoclax/azacytidine combination in a very old patient.
    Acta Haematol. 2023 May 17:1. doi: 10.1159/000531101.
    PubMed     Abstract available
    
    
    
47. WANG Y, Xue YJ, Jia YP, Zuo YX, et al
    Prognostic significance of CD20 expression in children with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.
    Acta Haematol. 2023 May 7:1. doi: 10.1159/000530849.
    PubMed     Abstract available
    
    
    April 2023
48. ALLEN C, Gautam S, Cheng W, Pine AB, et al
    Impact of Prophylactic Antibacterials on Coagulation Profiles and Bleeding in Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome.
    Acta Haematol. 2023 Apr 26:1-6. doi: 10.1159/000530153.
    PubMed     Abstract available
    
    
    
49. MCBRIDE A, Brokars J, Reddy SR, Chang E, et al
    An Analysis of Dasatinib Treatment Patterns in Patients with Chronic Myeloid Leukemia After Experiencing Pleural Effusion During Dasatinib Therapy.
    Acta Haematol. 2023 Apr 10. doi: 10.1159/000530512.
    PubMed     Abstract available
    
    
    
50. POPEK-MARCINIEC S, Zmorzynski S, Koczkodaj D, Marciniec M, et al
    CCL3 as possible negative prognostic factor in chronic lymphocytic leukemia.
    Acta Haematol. 2023 Apr 4. doi: 10.1159/000526397.
    PubMed     Abstract available
    
    
    February 2023
51. ZHUANG H, Li F, Si T, Renzhi P, et al
    High Expression of CD300A Predicts Poor Survival in Acute Myeloid Leukemia.
    Acta Haematol. 2023 Feb 6. doi: 10.1159/000529078.
    PubMed     Abstract available
    
    
    January 2023
52. GUISNEL C, Schirmer L, Morisset S, Robin M, et al
    On behalf of the SFGM-TC: prophylactic donor lymphocyte infusion in patients treated with allogeneic stem-cell transplantation for high-risk myelodysplastic syndrome and acute myeloid leukemia.
    Acta Haematol. 2023 Jan 5. doi: 10.1159/000528184.
    PubMed     Abstract available
    
    
    
53. HALAHLEH KA, Ma'koseh M, Sultan I, Rimawi DH, et al
    High Incidences of Acute and Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplants for Acute Myeloid Leukemia Using Thiotepa, Busulfan, and Fludarabine Pretransplant Conditioning.
    Acta Haematol. 2023;146:88-91.
    PubMed    
    
    
    
54. GORADIA N, Shastri A, Verma A, Feldman E, et al
    A Co-Management Model for Myeloid Malignancies That Evolved during the COVID-19 Pandemic.
    Acta Haematol. 2023;146:144-150.
    PubMed     Abstract available
    
    
    
55. HERSHENFELD SA, Atenafu EG, Chan S, Gupta V, et al
    Impact of Geographical Distance from Quaternary Treatment Center on Clinical Trial Participation, Intensive Induction Chemotherapy, and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia.
    Acta Haematol. 2023;146:366-372.
    PubMed     Abstract available
    
    
    
56. BURMEISTER T, Bullinger L, le Coutre P
    The Recurrent Atypical e8a2 BCR::ABL1 Transcript with Insertion of an Inverted 55 Base Pair ABL1 Intron 1b Sequence: A Detailed Molecular Analysis.
    Acta Haematol. 2023;146:413-418.
    PubMed     Abstract available
    
    
    
57. PAPADOPOULOU V, Schoumans J, Scarpelli I, Blum S, et al
    Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus Deletions or ETV6 Rearrangements.
    Acta Haematol. 2023;146:401-407.
    PubMed     Abstract available
    
    
    
58. TINAJERO J, Ngo D, Puing A, Koller P, et al
    Treatment Outcomes of Acute Myeloid Leukemia in Patients Living with Human Immunodeficiency Virus Receiving Antiretroviral Therapy: A Single-Center Experience.
    Acta Haematol. 2023;146:490-495.
    PubMed     Abstract available
    
    
    
59. TINAJERO J, Ngo D, Salhotra A, Koller P, et al
    Cladribine, Cytarabine, and Etoposide-Based Regimens Are Safe and Tolerable In Relapsed and Refractory Acute Myeloid Leukemia Patients.
    Acta Haematol. 2023;146:538-542.
    PubMed     Abstract available
    
    
    December 2022
60. AGAMEZ CAR, Torres JD, Caceres-Galvis C, Cabrera HB, et al
    Glomerulonephritis Secondary to Acute Promyelocytic Leukemia that Resolved after Induction Therapy.
    Acta Haematol. 2022 Dec 20. doi: 10.1159/000528088.
    PubMed     Abstract available
    
    
    November 2022
61. ZHOU L, Shan Z, Fan J
    Extracellular vesicles derived from human bone marrow stem cells inhibit acute lymphoblastic leukemia cell growth by inhibiting MAPK pathway via the miR-29b-3p/GDF15 axis.
    Acta Haematol. 2022 Nov 3. pii: 000527456. doi: 10.1159/000527456.
    PubMed     Abstract available
    
    
    October 2022
62. BURGESS M, Keane C, Tobin JW, Law SC, et al
    Resolution of melanoma to PD-1 blockade but simultaneous rapid progression of concomitant chronic lymphocytic leukemia.
    Acta Haematol. 2022 Oct 21. pii: 000527631. doi: 10.1159/000527631.
    PubMed     Abstract available
    
    
    
63. LAURICELLA C, Greco R, Mancini V, Motta V, et al
    Acute promyelocytic leukemia with del(6)(p22) and atypical bcr2 PML::RARA fusion transcript: a case report.
    Acta Haematol. 2022 Oct 5. pii: 000527316. doi: 10.1159/000527316.
    PubMed     Abstract available
    
    
    
64. TARANTINI F, Cumbo C, Parciante E, Anelli L, et al
    IRF4 gene expression on the trail of molecular response: looking at chronic myeloid leukemia from another perspective.
    Acta Haematol. 2022 Oct 4. pii: 000527173. doi: 10.1159/000527173.
    PubMed     Abstract available
    
    
    August 2022
65. NACHMIAS B, Krichevsky S, Filon D, Even-Or E, et al
    Monitoring minimal residual disease in RUNX1-mutated acute myeloid leukemia.
    Acta Haematol. 2022 Aug 5. pii: 000526353. doi: 10.1159/000526353.
    PubMed     Abstract available
    
    
    
66. HE X, Jiang Y, Yu X, He F, et al
    A gene signature comprising seven pyroptosis-related genes predicts prognosis in pediatric patients with acute myeloid leukemia.
    Acta Haematol. 2022 Aug 5. pii: 000526346. doi: 10.1159/000526346.
    PubMed     Abstract available
    
    
    July 2022
67. DENGLER J, Tesch H, Jentsch-Ullrich K, Gerhardt A, et al
    Treatment-free remission in real-world chronic myeloid leukemia patients: Insights from German hematology practices.
    Acta Haematol. 2022 Jul 29. pii: 000525935. doi: 10.1159/000525935.
    PubMed     Abstract available
    
    
    
68. BERGER T, Shacham Abulafia A, Shimony S, Pasvolsky O, et al
    Prevalence and Clinical Characteristics of Paraproteinemia Associated with Chronic Myeloid Leukemia.
    Acta Haematol. 2022 Jul 29. pii: 000526168. doi: 10.1159/000526168.
    PubMed     Abstract available
    
    
    
69. EDAHIRO T, Fukushima N, Otani T, Nakamori M, et al
    Progressive multifocal leukoencephalopathy in relapsed Ph+ acute lymphoblastic leukemia after cord blood transplantation and blinatumomab treatment: A case report and literature review.
    Acta Haematol. 2022 Jul 27. pii: 000526132. doi: 10.1159/000526132.
    PubMed     Abstract available
    
    
    
70. GOTO H, Ogawa C, Iida H, Horibe K, et al
    Safety and efficacy of blinatumomab in Japanese adult and pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia: final results from an expansion cohort.
    Acta Haematol. 2022 Jul 5. pii: 000525835. doi: 10.1159/000525835.
    PubMed     Abstract available
    
    
    June 2022
71. PETERLIN P, Garnier A, Le Bourgeois A, Jullien M, et al
    Dramatic recovery after etoposide phosphate infusion for hemophagocytic lymphohistiocytosis/macrophage activation syndrome following treatment with tisagenlecleucel in a young patient with relapsed acute lymphoblastic leukemia: a case report.
    Acta Haematol. 2022 Jun 20. pii: 000525576. doi: 10.1159/000525576.
    PubMed     Abstract available
    
    
    May 2022
72. ARRIGO G, D'Ardia S, Audisio E, Cerrano M, et al
    Gilteritinib in isolated breast relapse of FLT3positive acute myeloid leukemia: a case report and review of literature.
    Acta Haematol. 2022 May 17. pii: 000524878. doi: 10.1159/000524878.
    PubMed     Abstract available
    
    
    
73. TO AQ, Ciurea SO, Kongtim P
    Acquired Factor V Deficiency: A New Cause of Bleeding in Patients with Chronic Myeloid Leukemia and Extreme Leukocytosis?
    Acta Haematol. 2022 May 2. pii: 000524630. doi: 10.1159/000524630.
    PubMed     Abstract available
    
    
    March 2022
74. WANG ZY, Gao WH, Zhao HJ, Yin CR, et al
    Chemotherapy or Allogeneic Stem Cell Transplantation as Salvage Therapy for Patients with Refractory Acute Myeloid Leukemia: A Multicenter Analysis.
    Acta Haematol. 2022 Mar 1:1-11. doi: 10.1159/000511144.
    PubMed     Abstract available
    
    
    January 2022
75. KIMURA SI, Nakamura Y, Kawamura M, Takeshita J, et al
    Neutropenia in the First Cycle of Consolidation Chemotherapy with High-Dose Cytarabine Is Not Associated with the Incidence of Relapse in Adult Acute Myeloid Leukemia Patients in First Complete Remission.
    Acta Haematol. 2022 Jan 19. pii: 000522037. doi: 10.1159/000522037.
    PubMed     Abstract available
    
    
    
76. BIANCHI S, Capria S, Trisolini SM, Crisanti E, et al
    Myeloid Sarcoma: Diagnostic and Treatment Tools from a Monocentric Retrospective Experience.
    Acta Haematol. 2022;145:84-88.
    PubMed     Abstract available
    
    
    
77. LAFFERTY N, Salmon M, Cross NCP, Singer I, et al
    Chronic Eosinophilic Leukaemia Associated with JAK2 Exon 13 Insertion/Deletion Mutations.
    Acta Haematol. 2022;145:201-206.
    PubMed     Abstract available
    
    
    
78. UYGUN V, Karasu G, Yalcin K, Ozturkmen S, et al
    Timing of Initiation of Calcineurin Inhibitors in Pediatric Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: Effects on Survival, Relapse, and Cytokine Release Syndrome.
    Acta Haematol. 2022;145:362-370.
    PubMed     Abstract available
    
    
    
79. DESIKAN SP, Ravandi F, Pemmaraju N, Konopleva M, et al
    A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations.
    Acta Haematol. 2022;145:529-536.
    PubMed     Abstract available
    
    
    
80. LIU X, Cui MM, Zhu HZ, Fu PY, et al
    MiR-199a-3p Overexpression Suppressed Cell Proliferation and Sensitized Chronic Myeloid Leukaemia Cells to Imatinib by Inhibiting mTOR Signalling.
    Acta Haematol. 2022;145:484-498.
    PubMed     Abstract available
    
    
    December 2021
81. SHEN Y, Jia Y, Zhang R, Chen H, et al
    Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia.
    Acta Haematol. 2021 Dec 8:1-7. doi: 10.1159/000520446.
    PubMed     Abstract available
    
    
    November 2021
82. PLOTKA A, Lewandowski K
    BCR/ABL1-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy.
    Acta Haematol. 2021 Nov 24:1-9. doi: 10.1159/000519782.
    PubMed     Abstract available
    
    
    October 2021
83. TAKAHASHI S
    Kinase Inhibitors and Interferons as Other Myeloid Differentiation Inducers in Leukemia Therapy.
    Acta Haematol. 2021 Oct 21:1-9. doi: 10.1159/000519769.
    PubMed     Abstract available
    
    
    September 2021
84. CAI X, Wang J, Lu J, Jia Z, et al
    Adult Acute Myeloid Leukemia with the KMT2A-Mixed Lineage Leukemia T10 Fusion: An Analysis of 10 Cases Showed Common Features and Frequent Mutations in the RAS Signaling Pathway.
    Acta Haematol. 2021 Sep 22:1-7. doi: 10.1159/000518920.
    PubMed     Abstract available
    
    
    
85. YANG S, Zhu R, Li N, Feng Y, et al
    Ibrutinib in Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Lower Risk of Hepatitis B Virus Reactivation.
    Acta Haematol. 2021 Sep 20:1-9. doi: 10.1159/000518398.
    PubMed     Abstract available
    
    
    
86. MIZRAHI N, Kugler E, Hayman L, Yeshurun M, et al
    T-Lymphoblastic Leukemia/Lymphoma and Thymoma: A Case Report and Review of the Literature of a Rare Association.
    Acta Haematol. 2021 Sep 17:1-5. doi: 10.1159/000519033.
    PubMed     Abstract available
    
    
    June 2021
87. CRISTIANO G, Nanni J, Sartor C, Parisi S, et al
    Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement.
    Acta Haematol. 2021 Jun 15:1-5. doi: 10.1159/000516003.
    PubMed     Abstract available
    
    
    
88. DANYLESKO I, Canaani J, Shimoni A, Fein J, et al
    Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.
    Acta Haematol. 2021 Jun 8:1-7. doi: 10.1159/000515902.
    PubMed     Abstract available
    
    
    April 2021
89. ZHANG X, Liu H, Zheng C, Tang B, et al
    Outcomes of Adolescents and Young Adults Compared with Children with Acute Leukemia after Single-Unit Unrelated Cord Blood Transplantation Using Myeloablative Conditioning without Antithymocyte Globulin.
    Acta Haematol. 2021 Apr 13:1-11. doi: 10.1159/000507973.
    PubMed     Abstract available
    
    
    January 2021
90. SHAHIN OA, Chifotides HT, Bose P, Masarova L, et al
    Accelerated Phase of Myeloproliferative Neoplasms.
    Acta Haematol. 2021;144:484-499.
    PubMed     Abstract available
    
    
    
91. PARK HS, Son BR, Shin KS, Byeon S, et al
    The Prognostic Ability of RAS Pathway-Related Gene Mutations in Patients with Myeloid Neoplasms Treated with Hypomethylating Agents.
    Acta Haematol. 2021;144:649-659.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.